Abstract:Objective To analyze the effects of f prostatic hyperplasia on sexual function in patients with benign prostatic hyperplasia (BPH) by transurethral enucleation of the prostate.Methods 120 patients with BPH treated during May 2015 and June 2019 were included in our study according to the inclusion criteria and randomly divided into observation group (60 cases treated with ThuLEP) and control group (60 cases treated with TUPKP). Compare and analysis the international index of erectile function-5 (IIEF-5), International prostate symptom score (I-PSS), postvoid residual urine (PVR), maximum flow rate (MFR Qmax), hospital anxiety and depression scale (HADS), male sexual health questionnair ejaculatory dysfunction (MSHQ-EjD) and quality of life score (QOL) before and 6 months after surgery.Results The I-PSS of the control group and the observation group were (7.24 ± 2.65) and (7.10 ± 3.46), and there were no significant difference between the two groups (P > 0.05), but there were statistically significant differences between the two groups after operation and before operation. There were no statistically differences in PVR, MFR Qmax, and QOL between the two groups, but there were statistically significant difference between the two groups before surgery and after surgery. The IIEF-5 of the control group and the observation group were (14.27 ± 2.84) and (15.88 ± 3.05), there were statistically significant differences (P < 0.05). The scores of the observation group after surgery were also improved than that of before surgery (P < 0.05). The anxiety scores of HADS-A were (7.47 ± 3.12) and (7.61 ± 3.15) in two groups after surgery, and there were no statistically difference between the two groups (P > 0.05), but there were significantly significant difference between the two groups after surgery and before surgery. There were no difference between the two groups in male sexual health questionnair ejaculatory dysfunction (MSHQ-EjD) and depression score (HADS-D) before and after surgery.Conclusion Although ThuLEP and TUPKP can significantly improve BPH patients with poor urination and lower urinary tract symptoms caused by BPH, but the ThuLEP with 1.94 μm laser can be higher efficiency and less impact on sexual function.